One study on patients with major depressive disorder compared patients with hyperphagic versus hypophagic symptoms with healthy controls, finding differential effects of ghrelin depending on somatic symptom profile (Cerit et al., 2019)
Best practice: Match the peptide to the severity of the metabolic model (Standard obesity/T2D = Tirzepatide, Severe obesity/Lipolysis = Retatrutide)
Your provider will monitor your response and adjust your dose as needed
Results vary based on your dose, metabolism, and adherence to habits like diet and physical activity
Others struggle significantly during weeks 6-10 but feel normal afterward
Developed by Eli Lilly (the same company behind weight management injection Mounjaro), Retatrutide has shown promising early results in clinical trials for reducing body weight - in some cases even more significantly than current medications like Wegovy (semaglutide) or Mounjaro (tirzepatide)